Jane Street Group, LLC Uro Gen Pharma Ltd. Call Options Transaction History

Jane Street Group, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 17, 2021	SELL	$17.54 - $25.43 $438,500 - $635,750	-25,000 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$18.81 - $26.42 $1,880 - $2,642	-100 Reduced 0.4%	25,000 $482,000
Q2 2020 Aug 17, 2020	BUY	$16.5 - $29.7 $414,150 - $745,470	25,100 New	25,100 $656,000

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $260M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.